Derivative spectrophotometric method for simultaneous determination of ezetimibe and simvastatin in combined tablets
Open Access
- 31 December 2010
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 1 (4), 348-351
- https://doi.org/10.5155/eurjchem.1.4.348-351.110
Abstract
The introduced study portrays the development and validation of an effortless, speedy and selective first order derivative zero-crossing spectrophotometric method to estimate ezetimibe and simvastatin simultaneously in combined drug products over and above in the presence of ezetimibe alkaline degradation products. Ezetimibe and its alkaline degradates spectra showed zero-crossing point at 249 nm, so the amplitude at 249 nm could be used for calculating the concentration of simvastatin. While simvastatin and ezetimibe alkaline degradates spectra showed a zero-reading value at 261 nm, so ezetimibe could be determined by measuring the amplitude at 261 nm. Regression plots revealed good linear relationships in the concentration range 1-16 µg/mL with accuracy checked by conducting recovery studies; average recovery was 99.61 ± 1.183 and 100.47 ± 1.310 for ezetimibe and simvastatin, respectively. The suggested first derivative spectrophotometric method was successfully applied for the determination of the cited drugs in "Inegy 10/10, 10/20 and 10/40 tablets". Satisfactory results were obtained for the recovery of both drugs and were in good agreement with the labeled amounts. Method validation was estimated according to USP guidelines.Keywords
This publication has 28 references indexed in Scilit:
- HPLC Analysis for Simultaneous Determination of Atorvastatin and Ezetimibe in Pharmaceutical FormulationsJournal of Liquid Chromatography & Related Technologies, 2008
- Validation of a Stability-Indicating LC Method for Assay of Ezetimibe in Tablets and for Determination of Content UniformityChromatographia, 2007
- Stability-Indicating HPTLC Method for Simultaneous Determination of Ezetimibe and SimvastatinChromatographia, 2007
- Simultaneous Determination of Ezetimibe and Simvastatin in Pharmaceutical Formulations by Dual-Mode Gradient LCChromatographia, 2007
- Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: Quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bileJournal of Chromatography B, 2007
- Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assayJournal of Pharmaceutical and Biomedical Analysis, 2006
- Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Ezetimibe in Human Plasma and Pharmaceutical FormulationsChromatographia, 2006
- Liquid chromatography–negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2006
- A LC–MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1Journal of Chromatography B, 2006
- Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2005